{"text": "enter gild feb 11 2022 68 00 puts buy in price 5 69 6 15 take profit 6 88 stop bleeding 5 01 roi potential 21 exit within 67 minutes short scalp courtesy of"}
{"text": "gild phase 2 3 interim data evaluating the safety tolerability and clinical outcomes of veklury remdesivir in pediatric patients with covid 19 presented at croi 2022"}
{"text": "gild biktarvy demonstrates high efficacy and durable viral suppression at five years in treatment nave adults"}
{"text": "gild gild gild your boat slowly down the trow"}
{"text": "rsi25 argo 41 18 3 83 26 04 31 24 31 78 11 17 gild 62 22 0 70 2 63 14 03 5 68 22 93"}
{"text": "gilead reports new data from phase 2 3 study of veklury gild"}
